Revolutionizing Outcomes in Gynecologic Surgery: The Pivotal Role of Iron Deficiency Anemia

November 9, 2020

Iron deficiency anemia is a far-reaching condition of immense clinical impact in women’s health, with implications ranging from the global, epidemiological scale, to treatment by individual OB/GYNs and gynecologic surgeons, and most importantly, to individual patient outcomes. As such, this educational initiative is designed to address the myriad challenges of iron deficiency anemia (IDA) in women’s health using a dynamic, multifaceted approach targeted to OB/GYNs and gynecologic laparoscopists. This initiative will provide a review of the epidemiology of IDA, including perioperative obstetrical morbidity and mortality implications, as well as equip OB/GYNs and laparoscopists with the tools they need to identify patients at high risk for IDA within their practices and properly prevent, diagnose, and treat IDA in those patients. Abnormal uterine bleeding (AUB) will be emphasized as a preeminent cause of IDA in women, and attendees will be given strategies they can employ to overcome the harmful cultural stigmas surrounding AUB. And lastly, using a case-based approach designed for the interprofessional team, this activity will evaluate currently-available IV and oral iron supplementation modalities, with a focus on tailored treatment strategies for surgical patients refractory to oral therapy.


Presented by Creative Educational Concepts, Inc. (CEC) and supported through an independent educational grant from American Regent.

Target Audience

Surgical Gynecologists/gynecologic laparoscopists in practice and in training, as well as other healthcare professionals in the field of gynecology attending the AAGL Virtual Global Congress on MIGS.

Learning Objectives

  1. Review the epidemiology of iron deficiency anemia, examining the profundity of its impact on perioperative obstetrical morbidity and mortality, and on patient quality of life.
  2. Recognize AUB as a prominent IDA etiology, and describe how the cultural normalization of heavy menstrual bleeding (HMB) leads to under-diagnosis of IDA. 
  3. Identify patients in the OB/GYN and gynecologic surgery practice settings who are at an elevated risk for developing IDA.
  4. Discuss clinically-appropriate iron studies for the diagnosis and assessment of IDA prior to surgery, including when to order and how to interpret results.
  5. Using a case-based format designed for the interprofessional team, evaluate available iron supplementation approaches, including IV and oral modalities, and formulate individualized treatment plans for the surgical patient with IDA who is refractory to oral therapy.

Additional Information

AttachmentSize
General Information1.1 MB
Handout and References2.78 MB
Course summary
Available credit: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
Course opens: 
10/21/2020
Course expires: 
12/09/2020
Event starts: 
11/09/2020 - 2:00pm
Event ends: 
11/09/2020 - 3:00pm
Rating: 
0

Agenda:

  5 min   Welcome and Introductions/Pre-test

10 min   Illuminating a Hidden Problem: IDA Epidemiology and Clinical Gravity in Gynecologic Surgery

15 min   A Review for the Gynecologic Laparoscopist: Abnormal Uterine Bleeding (AUB) and Other IDA Risk Factors

20 min   Optimizing Perioperative Outcomes: Employing Iron Supplementation to Improve Morbidity and Mortality

10 min   Conversations with the Experts: Audience Q&A/Post-test 

Live Virtual Event
Part of the AAGL Annual Meeting
2:00pm EST
United States

Lee P. Shulman MD, FACMG, FACOG (Activity Chair)
The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Medical Director, Insight Medical Genetics
Medical Director, Reproductive Genetics Innovations
Adjunct Professor, Department of Medicinal Chemistry and Pharmacognosy
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois

Lee P. Shulman, MD is the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Medical Director for Insight Medical Genetics and Reproductive Genetics Innovations. Dr. Shulman is an Adjunct Professor in the Department of Medicinal Chemistry and Pharmacognosy at the University of Illinois at Chicago College of Pharmacy. A Fellow of the American College of Obstetricians and Gynecologists and a Founding Fellow of the American College of Medical Genetics, Dr. Shulman is a member of numerous regional, national and international organizations that pertain to the health and care of women. His work has been recognized regionally and nationally; most recently, he was again included in the list of “Top Doctors” in Chicago (2007-19) and the United States (2005-19).  Dr. Shulman served as Chair of the Board of Trustees of the Association of Reproductive Health Professionals from 2006-2008, is a Past President of the Central Association of Obstetricians and Gynecologists and the current Chair of the Fetoscopy Working Group.  A frequent contributor to the peer-reviewed and informational literature with over 200 peer-reviewed articles and 60 book chapters, Dr. Shulman’s major research interests are in contraception, reproductive and cancer genetics, menopause, women’s healthcare advocacy and botanical interventions in women’s health.

 

Karen Chiu Wang, MD
Fellowship Director, AAGL Fellowship in Minimally Invasive Gynecologic Surgery
Assistant Professor of Gynecology and Obstetrics
Johns Hopkins Medicine
Baltimore, Maryland

 

Karen Wang, M.D., is a fellowship-trained minimally invasive gynecologic surgeon whose primary clinical focus is on the surgical management of benign gynecologic conditions, including abnormal bleeding, fibroids, endometriosis, pelvic pain and office procedures. Her research interests include quality and safety, surgical outcomes and surgical training. She is the current Director in Minimally Invasive Gynecologic Surgery and Fellowship Director at Johns Hopkins Hospital.


Planner and Faculty Disclosures:
In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity. 

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Planners: 
Bryan Taylor, PharmD–has no relevant financial relationships to disclose in relation to the content of this activity.

Lee P. Shulman MD, FACMG, FACOG–has disclosed that he is a consultant for Bayer, Biogix, Daiichi Sankyo, Natera, and Medicem. Dr. Shulman receives grant/research support from Merck and is in the Speakers Bureau for Medicem.

Authors/Presenters:

Lee P. Shulman MD, FACMG, FACOG–has disclosed that he is a consultant for Bayer, Biogix, Daiichi Sankyo, Natera, and Medicem. Dr. Shulman receives grant/research support from Merck and is in the Speakers Bureau for Medicem.

Karen Chiu Wang, MD–has no relevant financial relationships to disclose in relation to the content of this activity.

Peer Reviewers:

Jessica Kiley, MD, MPH–has no relevant financial relationships to disclose in relation to the content of this activity.

Susan Wysocki, WHNP, FAANP–has no relevant financial relationships to disclose in relation to the content of this activity.

Stephanie Howard, PA-C–has no relevant financial relationships to disclose in relation to the content of this activity.

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine (ACCME)
CEC designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (ANCC)
This activity is designated for 1.0 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Physician Assistants (AAPA)
Creative Educational Concepts has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Upon completion of a CE request form, statements of credit for physicians, physician assistants, and nurses will be issued within 30 business days.

Available Credit

  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
Please login or register to take this course.